Respiratory disease testing: Key market research findings
- Augmented use of multiplex devices
- Increased prevalence of immunodiagnostic techniques
Technavio has added a new market research report on the global respiratory disease testing market, to its respiratory disease portfolio. The global respiratory disease testing market is expected to grow at a more than 8% between 2015 and 2019, owing to the augmented availability of respiratory disease testing devices like portable systems and multiplex assays. The Americas is the major contributor to the global respiratory disease testing market, accounting for around 48% of the overall market revenue. The region has an advanced healthcare infrastructure and various governments are carrying out awareness programs respiratory diseases and subsequent use of related testing devices.
The new industry research report from Technavio discusses in detail the key drivers and trends responsible for the growth of this market and its sub-segments.
“Of late, the respiratory disease testing market is witnessing increased usage of multiplex devices. These devices are used to detect two or more respiratory disease-causing pathogens simultaneously. Also, they provide sensitive and comprehensive diagnosis, which has improved patient care and the drug delivery system. For instabce, QIAGEN’s RespiFinder RG panel can detect 21 pathogens causing respiratory diseases such as acute respiratory tract infection in four hours,” says Imran Mushtaq, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
Technavio’s market research analyst estimates the others segment to lead the global market for respiratory disease testing during the forecast period. This segment includes tests like chemical assays and immunodiagnostics, which are useful for identifying the microorganisms responsible for respiratory diseases like bronchitis and pneumonia. These tests cover 50% of the overall market, and are used to detect microorganisms responsible for respiratory diseases such as bronchitis and pneumonia.
Global respiratory disease testing market by IVD test
Source: Technavio, 2015
The major players in the global respiratory disease testing market include Alere, CareFusion, COSMED, Smiths Medical, Nihon Kohden, and Philips Healthcare. This market is characterized by the presence of intense competition among the leading manufacturers of respiratory disease testing devices. Vendors that have the ability to provide cost-effective, high-end products without compromising on quality are expected to gain maximum prominence during the forecast period.
A more detailed analysis is available in the Technavio report, Global Respiratory Disease Testing Market 2015-2019.
We can customize reports by other regions and specific segments upon request.
Other Related Reports:
- Global In-Vitro Diagnostics Infectious Disease Testing Market 2015-2019
- Global Respiratory Protection Equipment (RPE) Market 2015-2019
Further Reading:
